Evidence map›Paper›PMID 36311709›Full record

ArticleFrontiers in immunology2022

Therapeutic effect on Alveolar echinococcosis by targeting EM-Leucine aminopeptidase.

Zhen Zhou, Pei Zhou, Yalin Mu, Lei Wang, Zhenjin Cao, Shizhong Dong, Haihua Bao, Baoliang Yang, Minyuan Xin, Runle Li and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Current status and future prospects ofVeterinary and animal science · 2024
    Review
  3. Article
  4. Ubenimex combined with Albendazole for the treatment ofFrontiers in veterinary science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Zhen ZhouResearch Center for High Altitude Medicine, Qinghai University, Xining, China.
Pei ZhouResearch Center for High Altitude Medicine, Qinghai University, Xining, China.
Yalin MuDepartment of Medical Imaging Center, Qinghai University Affiliated Hospital, Xining, China.
Lei WangDepartment of Pathology, The Second Xiangya Hospital DE Central South University, Changsha, China.
Zhenjin CaoDepartment of Medical Imaging Center, Qinghai University Affiliated Hospital, Xining, China.
Shizhong DongDepartment of Medical Imaging Center, Qinghai University Affiliated Hospital, Xining, China.
Haihua BaoDepartment of Medical Imaging Center, Qinghai University Affiliated Hospital, Xining, China.
Baoliang YangDepartment of ENT, Qinghai Red Cross Hospital, Xining, China.
Minyuan XinResearch Center for High Altitude Medicine, Qinghai University, Xining, China.
Runle LiResearch Center for High Altitude Medicine, Qinghai University, Xining, China.
Ri-Li GeResearch Center for High Altitude Medicine, Qinghai University, Xining, China.
Feng TangResearch Center for High Altitude Medicine, Qinghai University, Xining, China.
Qinghai University · CNQinghai University Affiliated Hospital · CNCentral South University · CNQinghai Red Cross Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alveolar echinococcosis (AE) is a parasitic disease caused by

Indexed as

CystsEchinococcosisEchinococcus multilocularisAnimalsImmunoglobulin GLeucyl AminopeptidaseMiceMice, Inbred BALB CImmunoglobulin GLeucyl AminopeptidaseE. multilocularisimmuneLeucine aminopeptidaseUbenimexVaccine

Identifiers

PMID36311709
PMCPMC9614657
OpenAlexW4306167154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.